Systems and methods for targeted lung denervation of chronic obstructive pulmonary disease
By designing a medical system for targeted lung denervation, using expandable elements and nitinol shape memory alloy injection tubes, precise treatment of targeted lung denervation is achieved, and the thermal energy application in the prior art is solved The collateral tissue impact problem improves the safety of treatment and drug delivery efficiency.
Patent Information
- Application Number
- CN202380029475.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-04
- Filing Date
- 2023-03-30
- Publication Date
- 2024-11-19
AI Technical Summary
Existing targeted pulmonary denervation techniques tend to affect collateral tissues when heat energy is applied, leading to the risk of inaccurate treatment and side effects.
A medical system is designed, including expandable elements and injection tubes, delivering therapeutic drugs through therapeutic fluid supply sources, and using an inflatable-deflation cavity and a nitinol shape memory alloy injection tube to achieve targeted lung deletion Accurate treatment of nerves.
Improves the accuracy and safety of treatment, reduces the impact on collateral tissues, and enhances the efficiency and distribution of drug delivery.
Smart Images

Figure CN118984724A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application is related to and claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 326,943, filed on April 4, 2022, entitled “SYSTEMS AND METHODS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE TARGETED LUNG DENERVATION,” under 35 U.S.C. §119(e), the entire contents of which are incorporated herein by reference. Technical Field
[0003] The present technology generally relates to devices, systems, and related methods for denervating lung tissue to treat chronic obstructive pulmonary disease (COPD). Background Art
[0004] COPD is a chronic inflammatory lung disease that causes airflow obstruction from the lungs. Symptoms include dyspnea, cough, mucus production and wheezing. People with COPD have an increased risk of developing heart disease, lung cancer and other diseases. Targeted lung denervation (TLD) is a surgical procedure in which a catheter is advanced through a bronchoscope to a target area in the target bronchus to denervate the target area. Existing medical systems use thermal energy to denervate tissue via cryogenic fluids and / or radio frequency (RF) energy. However, when thermal energy is applied to the target treatment area, collateral tissue may be unintentionally affected. Summary of the invention
[0005] The technology of the present disclosure generally relates to systems and devices for targeted pulmonary denervation and methods of use thereof.
[0006] In one embodiment, a medical system includes a therapeutic fluid supply source containing a therapeutic drug and a medical device in fluid communication with the therapeutic fluid supply source. The medical device includes an expandable element and an injection tube coupled to the expandable element. The injection tube defines a port. The injection tube is in communication with the therapeutic fluid supply source and is configured to deliver the therapeutic drug through the port.
[0007] In one aspect of this embodiment, the medical device further comprises an elongated body having a proximal portion, a distal portion opposite to the proximal portion, and a cavity passing through the elongated body; and an inner shaft disposed in the cavity. The inner shaft has a distal portion proximal to the distal portion of the elongated body.
[0008] In another aspect of this embodiment, the medical system further comprises an inflation fluid supply reservoir and an inflation-deflation chamber extending through the inner shaft and extending out through the distal portion of the inner shaft. The inflation-deflation chamber defines a second port. The inflation-deflation chamber is in fluid communication with the inflation fluid reservoir and is configured to deliver inflation fluid to the inner chamber of the expandable element through the second port.
[0009] In another aspect of this embodiment, the expandable element surrounds at least a portion of the distal portion of the inner shaft.
[0010] In another aspect of this embodiment, the injector tube has a proximal portion disposed within the elongated body and a distal portion coupled to the expandable element.
[0011] In another aspect of this embodiment, an end portion of the injection tube extends outwardly from the expandable element.
[0012] In another aspect of this embodiment, the injection tube defines an injection lumen therethrough, and an end portion of the injection tube defines the port.
[0013] In another aspect of this embodiment, the therapeutic fluid supply source is disposed within a fluid pump. The fluid pump is configured to initiate delivery of the therapeutic drug through the syringe.
[0014] In another aspect of this embodiment, the therapeutic drug is delivered through the syringe at a pressure of about 50 psi to 2000 psi.
[0015] In another aspect of this embodiment, the diameter of the injection tube tapers toward the end.
[0016] In another aspect of this embodiment, the medical device further includes a plurality of injection tubes spaced apart from one another around the outer surface of the expandable element.
[0017] In another aspect of this embodiment, each syringe is constructed from at least one of nitinol and a shape memory alloy.
[0018] In yet another embodiment, a medical system for targeted lung denervation includes a therapeutic fluid supply containing a therapeutic drug and a medical device in fluid communication with the therapeutic fluid supply. The medical device includes an expandable element and an injection tube coupled to the expandable element. The injection tube defines a port. The injection tube is in communication with the therapeutic fluid supply and is configured to deliver the therapeutic drug through the port.
[0019] In one aspect of this embodiment, the medical system further includes a hub disposed between and in communication with the therapeutic fluid supply source and the medical device.
[0020] In one aspect of this embodiment, the medical system further includes an inflation fluid supply reservoir in fluid communication with the medical device.
[0021] In another aspect of this embodiment, the hub includes a first portion coupled to the inflation fluid supply reservoir and a second portion coupled to the therapeutic fluid supply source.
[0022] In another aspect of this embodiment, when inflated, the expandable element extends partially around the outer surface of the injection tube.
[0023] In another aspect of this embodiment, the injection tube has a proximal portion and a distal portion opposite the proximal portion. The distal portion of the injection tube is coupled to the expandable element.
[0024] In another aspect of this embodiment, the expandable element includes a recessed area.The distal portion of the injection tube is received in the recessed area.
[0025] In yet another embodiment, a method for targeted pulmonary denervation includes providing a therapeutic fluid supply source having a therapeutic drug and a medical device in fluid communication with the therapeutic fluid supply source; advancing the medical device through the trachea of a mammal and positioning the expandable element within a target bronchus; inflating the expandable element so that the distal portion of the injection tube pierces the wall of the target bronchus and contacts the target tissue area; and delivering the therapeutic drug to the target tissue area to denervate the target bronchus. The medical device includes an expandable element and an injection tube, the injection tube having a proximal portion and a distal portion. The distal portion is coupled to the expandable element and extends outwardly from the expandable element, and is configured to deliver the therapeutic drug to the target tissue area within the target bronchus.
[0026] The details of one or more aspects of the present disclosure are set forth in the following drawings and description. Other features, objectives, and advantages of the techniques described in the present disclosure will be apparent from the description and drawings, and from the claims. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] A more complete understanding of the present invention and its attendant advantages and features will be more readily obtained by referring to the following detailed description when considered in conjunction with the accompanying drawings, in which:
[0028] Figure 1 An example medical system constructed in accordance with the principles of the present invention is shown;
[0029] Figure 2 shows a side view of a medical device constructed in accordance with the principles of the present invention, the medical device having an expandable element and a plurality of injection tubes;
[0030] Figure 3 Shows Figure 1 A front cross-sectional view AA of the medical device;
[0031] Figure 4 Shows Figure 1 and Figure 3 Positioning of the medical device within the target bronchus; and
[0032] Figure 5 A flow chart of an exemplary method constructed in accordance with the principles of the invention is shown. DETAILED DESCRIPTION
[0033] It should be understood that the various aspects disclosed herein may be combined in combinations different from those specifically presented in the specification and drawings. It should also be understood that, depending on the example, certain actions or events of any of the processes or methods described herein may be performed in a different order, may be added, merged, or omitted entirely (e.g., not all described actions or events may be required to perform these techniques). In addition, although for clarity, certain aspects of the present disclosure are described as being performed by a single module or unit, it should be understood that the techniques of the present disclosure may be performed by a combination of units or modules associated with, for example, a medical device.
[0034] In one or more examples, the described techniques can be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions can be stored as one or more instructions or codes on a computer-readable medium and executed by a hardware-based processing unit. The computer-readable medium may include a non-transitory computer-readable medium that corresponds to a tangible medium, such as a data storage medium (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and can be accessed by a computer).
[0035] Instructions may be executed by one or more processors, such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuits. Thus, the term "processor" as used herein may refer to any of the foregoing structures or any other physical structure suitable for implementing the described techniques. Additionally, these techniques may be fully implemented in one or more circuits or logic elements.
[0036] Referring now to the drawings, wherein like reference numerals represent like elements, Figure 1 1 is an exemplary medical device for targeted lung denervation (TLD) constructed according to the principles of the present application and generally designated "10". The medical system 10 is configured for use in the trachea and lungs of a mammalian patient for TLD. In one configuration, the medical system 10 includes a medical device 11 having an elongated body 12 sized and configured to pass through the trachea of a mammal and in a target bronchus 13 ( Figure 4 1 . The elongated body 12 includes a proximal portion 14 and a distal portion 16 opposite the proximal portion 14. The elongated body 12 defines a cavity sized and configured to allow passage of a rigid or semi-rigid inner shaft 18 that can be slidably and / or rotatably moved relative to the elongated body 12. The inner shaft 18 has a proximal portion 20 and a distal portion 22 proximal to the distal portion 16 of the elongated body 12. Figure 1 As shown, the distal portion 22 of the inner shaft 18 extends at least partially through the opening defined by the distal portion 16 of the elongated body 12 .
[0037] The system 10 also includes an expandable element 24 that is coupled to and / or partially surrounds the distal portion 22 of the inner shaft 18. The expandable element 24 can be a single-walled or double-walled balloon that is sized and configured to contact the wall of the target bronchus and / or create a seal within the target bronchus when inflated. The inner shaft 18 can further define a lumen that is sized and configured to allow a guidewire and / or an inflation-deflation conduit or lumen 26 to pass therethrough and extend therethrough and out from the distal end of the distal portion 22 of the inner shaft 18. Figure 1 As shown, in some configurations, the inflation-deflation chamber 26 can be configured for bidirectional flow, thus allowing inflation and deflation of the expandable element 24 to be performed using a single chamber. The inflation-deflation chamber 26 defines at least one opening, orifice, or port 27 that allows inflation fluid to be delivered to and discharged from the inner chamber 29 of the expandable element 24. The inflation-deflation chamber 26 can be directly coupled to an inflation fluid supply reservoir 28 or a fluid source containing a fluid such as, for example, saline, air, or refrigerant, or can be coupled to the inflation fluid supply reservoir 28 by using a hub as an intermediate mechanism (discussed in more detail below).
[0038] Continue to refer Figure 1 The medical device 11 further includes at least one injection tube 30. Each injection tube 30 extends through the lumen of the elongated body 12 parallel to the inner shaft 18 and through an opening defined at the distal portion 16 of the elongated body 12. Figures 1 to 4As shown, the distal portion 32 of each injection tube 30 is coupled, mounted, attached, or otherwise attached to the outer surface of the expandable element 24. The distal portion 32 of each injection tube 30 includes an end portion 34 that is disposed at a certain angle and extends further outward toward the target tissue (and away from the expandable element 24). In some configurations having more than one injection tube 30 (e.g., such as Figures 1 to 3 ), each syringe 30 can be spaced around the outer surface of the expandable element 24 so that no two syringes are in contact with each other. It should be understood that although the syringes 30 can be evenly spaced around the outer surface of the expandable element 24, the syringes 30 can also have uneven spacing between each other. In one example configuration, the medical device 11 can include four syringes 30. However, it should be understood that the medical device 11 can also include 1, 2, 3, 5, 6, 7, 8, or any number of syringes 30 as desired by the clinician.
[0039] Reference now Figures 1 to 3 ,like Figure 2 As shown, each syringe 30 can be coupled to the expandable element 24 in a manner such that the syringe only minimally affects the outer diameter of the expandable element 24 when inflated. This may be a result of the syringe 30 being formed of a lightweight material that allows the expandable element 24 to be easily inflated without experiencing resistance from the syringe 30 sufficient to indent or otherwise restrict the expansion of the expandable element 24. However, as Figure 1 and Figure 3 As shown, the injection tube 30 can be configured such that when extending from the distal portion 22 of the elongated body 12, the distal portion 32 of the injection tube 30 can extend outward until the tube 30 reaches a predetermined maximum diameter that is less than the maximum diameter of the expandable element 24. This results in the expandable element 24 being inflated (e.g., Figure 3 ), the distal portion 32 recesses the expandable element 24 inwardly. In other words, the injection tubes 30 can have a slight stiffness that allows the expandable element 24 to partially surround each injection tube 30 when the expandable element 24 is inflated. Therefore, in some embodiments, when inflated, the expandable element 24 can define a recessed portion 36 or groove that is sized and configured to receive the distal portion 32 of the corresponding injection tube 30 when the injection tube 30 is coupled to the expandable element 24. The injection tube 30 can remain in the recessed portion 36 or groove and be partially surrounded by at least a portion of the expandable element 24 throughout the duration of the treatment procedure (i.e., during the inflation phase and the treatment phase). As Figure 4As shown, the end portion 34 of each injection tube 30 extends outward toward the bronchial wall 37, so that when the expandable element 24 is inflated, the end portion 34 contacts and pierces the smooth muscle tissue of the bronchial wall 37, so that the therapeutic fluid 39 can be delivered to the target tissue 41, which in some embodiments includes cartilage. However, in other configurations, the end portion 34 can alternatively contact but not pierce the bronchial wall 37, or the end portion 34 can be close to but not pierce the bronchial wall 37. In addition, in some configurations, the distal portion 32 of each injection tube 30 can taper inwardly toward the end portion 34 to define a sharp or pointed edge, thereby more easily piercing the bronchial wall 37. However, in other configurations, the injection tube 30 can have a uniform diameter throughout its entirety, so that the distal portion 32 does not form a sharp or pointed edge at the end portion 34. It should be understood that although the bronchial wall 37 and target tissue 41 have been shown as shaded areas for ease of illustration, the bronchial wall 37 and target tissue 41 may each have a unique shape, size, and curvature that is unique to each particular patient.
[0040] Each injection tube 30 can be constructed of at least one of nitinol and a shape memory alloy so that the tube 30 can be advanced and retracted within the elongated body 12 before and after a treatment procedure. When the injection tube is advanced through the elongated body 12, the distal portion 32 is substantially linear. However, because the end portions 34 are biased to extend outward to contact tissue, once the end portions 34 of each injection tube 30 pass through the opening defined at the distal portion 14 of the elongated body 12, these end portions transition from a generally linear configuration to an extended or protruding configuration (e.g., Figure 1 Each syringe 30 defines an injection lumen in fluid communication with a therapeutic fluid supply source 38 (e.g., a syringe, a fluid chamber, a fluid reservoir, a fluid pump) containing a therapeutic fluid 39 and an orifice, opening, or port 40 at an end portion 34, the orifice, opening, or port being sized and configured to allow the therapeutic fluid 39 to be delivered through the injection lumen 30 and to a target tissue region 41. As described herein, the therapeutic fluid 39 contains a therapeutic drug or chemical (e.g., alcohol, acetic acid, phenol, glycerol, hypertonic saline, and ). Additionally, in other embodiments, the therapeutic fluid 39 may be a chemical adjuvant that can render the treated tissue more sensitive to ablative therapy and may inhibit the rate at which tissue regrowth occurs at the ablation site.
[0041] Reference again Figure 1, the system 10 also includes a hub 42 disposed between the inflation fluid supply reservoir 28, the therapeutic fluid supply source 38, and the elongated body 12. The hub 42 is provided with an inflow-outflow connector 44 that is coupled to the inflation fluid reservoir and allows the inflation-deflation chamber 26 to be in fluid communication with the inflation fluid supply reservoir 28. The hub 42 also includes an opening or orifice that is sized and configured to receive a portion of a delivery conduit 46 coupled to the therapeutic fluid supply source 38. The proximal portion 14 of the elongated body 12 is coupled to the hub 42, and the hub 42 is sized and configured to receive the proximal portion 20 of the inner shaft 18 and the proximal portion 48 of each syringe 30.
[0042] In some embodiments, the inflation fluid supply reservoir 28 can be disposed within the console 50. The console 50 can be coupled or connected to the inflow-outflow connector 44 of the hub 42 via one or more cables, tubes, or connectors 51. The console 50 can include a processing circuit 52 having a processor 54 and a memory 56 in communication with the processor 54. The memory 56 can be programmed and / or configured to store instructions that, when executed by the processor 54, configure the processor 54 to execute instructions or algorithms for providing automatic operation and execution of features, sequences, calculations, or procedures described herein and / or required for a given medical procedure, such as, for example, initiating inflation and / or deflation of the expandable element 24. Figure 1As shown, the console 50 may also include one or more other system components (such as one or more displays 58, user input devices, mapping and / or navigation systems) or be in electrical communication with the one or more other system components for collecting information from the user and transmitting information to the user. As used herein, for simplicity, the term "console 50" may include any system component that is not a part of the medical device 11 itself, except for the therapeutic fluid supply source 38, regardless of whether the component is physically located inside or outside the console 50. In an embodiment including a navigation system (not shown), the navigation system may be an independent system that communicates with the console 50, or may be included in or integrated with the console 50. The console 50 may also include one or more components for delivering one or more energy forms used by the system. For example, if the system 10 is also used to deliver cryotherapy, the console 50 may include a supply source of cryogenic fluids such as coolants, cryogenic refrigerants, etc., an exhaust or scavenging system for recovering or discharging used fluids for reuse or disposal, and various control mechanisms. However, in some embodiments, the inflation fluid supply reservoir 28 can be a supply source of cryogenic fluid for simultaneously inflating the expandable element 24 and ablating or denervating the target tissue. In addition to providing a drain function for the fluid or coolant supply source, the console 50 can also include pumps, valves, controllers, etc. to recover and / or recirculate the fluid delivered to the fluid pathway of the medical device 11. In addition, a vacuum pump (not shown) in the console 50 can create a low-pressure environment in one or more conduits within the medical device 11, so that the fluid is drawn into the conduit / cavity of the elongated body 12 away from the distal portion 16 of the elongated body 12 and toward the proximal portion 14. Additionally or alternatively, the console 50 can include an energy source as a treatment or diagnostic mechanism, which is connected to a treatment electrode (not shown) disposed around the outer surface of the expandable element 24. In addition, the energy source (not shown) can be a radio frequency generator having multiple output channels, each of which is coupled to a separate treatment electrode. The radio frequency generator can operate in one or more operating modes.
[0043] In some embodiments, the therapeutic fluid supply source 38 can be a supply source of therapeutic fluid disposed in a high pressure pump (e.g., a high pressure syringe pump) that is configured to deliver (e.g., deliver at 50 psi to 2000 psi) a therapeutic fluid through a syringe 30 with a high pressure jet to form a pinhole in the tissue / vessel wall of the target tissue region and pierce beyond the tissue vessel wall. In some such embodiments, the end portion 34 of each syringe 30 can be very close to but not in contact with the target tissue region. This can help reduce or eliminate the risks associated with piercing the tissue within the syringe 30. For example, because the syringe 30 does not pierce the tissue when delivering the high pressure jet, there is less risk at the end of the treatment procedure because the syringe 30 does not need to be removed from the pierced tissue (and may damage the incidental tissue when removed). Additionally, when compared to delivery via tissue piercing administration, delivering therapeutic drugs with a high pressure jet can result in enhanced drug distribution.
[0044] Reference now Figure 5 , an example method according to the principles of the present application is shown. The method includes providing a medical device 11 in communication with a console 50 having an inflation fluid reservoir 28 and a therapeutic fluid supply source 38 disposed therein (box S500). The medical device 11 including the expandable element 24 and the injection tube 30 is then advanced through the patient's trachea and positioned proximate to a target tissue region within a target bronchus (box S502). Once in the desired position, the processing circuit 52 of the console 50 is configured to initiate delivery of inflation fluid to the medical device 11 to inflate the expandable element 24 so that the end portion 34 of each injection tube 30 pierces the tissue wall of the target tissue region (box S504). The clinician can then manually or automatically initiate delivery of fluid from the therapeutic fluid supply source 38 to the medical device 11 and through the injection tube 30 until the therapeutic fluid is dispersed within the target tissue region and denervates the target bronchus (box S506).
[0045] It will be appreciated by those skilled in the art that the present invention is not limited to the contents specifically shown and described above. In addition, unless otherwise indicated above, it should be noted that all drawings are not drawn to scale. Without departing from the scope and spirit of the present invention, various modifications and variations are possible according to the above teachings, and the scope and spirit of the present invention are limited only by the appended claims.
Claims
1. A medical system, comprising: a therapeutic fluid supply containing a therapeutic drug; a medical device in fluid communication with the therapeutic fluid supply and comprising: expandable elements; and An injection tube is coupled to the expandable element and defines a port, the injection tube being in fluid communication with the therapeutic fluid supply and configured to deliver the therapeutic drug through the port.
2. The medical system according to claim 1, wherein the medical device further comprises: an elongated body having a proximal portion, a distal portion opposite the proximal portion, and a lumen extending through the elongated body; and An inner shaft is disposed within the lumen, the inner shaft having a distal portion proximate the distal portion of the elongated body.
3. The medical system according to claim 2, further comprising: an inflation fluid supply reservoir; and an inflation-deflation lumen extending through the inner shaft and out through the distal portion of the inner shaft, the inflation-deflation lumen defining a second port, the inflation-deflation lumen being in fluid communication with the inflation fluid reservoir and being configured to deliver inflation fluid to the inner chamber of the expandable element through the second port.
4. The medical system of claim 3, wherein the expandable element surrounds at least a portion of the distal portion of the inner shaft.
5. The medical system of claim 4, wherein the syringe has a proximal portion disposed within the elongated body and a distal portion coupled to the expandable element.
6. The medical system of claim 5, wherein an end portion of the injection tube extends outwardly from the expandable element.
7. The medical system of claim 6, wherein: The injection tube defines an injection lumen therethrough; and The end portion of the syringe defines the port.
8. The medical system of claim 7, wherein the therapeutic fluid supply is disposed within a fluid pump configured to initiate delivery of the therapeutic drug through the syringe.
9. The medical system of claim 8, wherein the therapeutic drug is delivered through the syringe at approximately 50 psi to 2000 psi.
10. The medical system of claim 9, wherein a diameter of the injection tube tapers toward the end portion.
11. The medical system of claim 10, wherein the medical device further comprises a plurality of injection tubes spaced apart from one another around the outer surface of the expandable element.
12. The medical system of claim 11, wherein each syringe is constructed of at least one of nitinol and a shape memory alloy.
13. A medical system for targeted pulmonary denervation, the medical system comprising: a therapeutic fluid supply containing a therapeutic drug; and a medical device in fluid communication with the therapeutic fluid supply and comprising: expandable elements; and An injection tube is coupled to the expandable element and defines a port, the injection tube being in communication with the therapeutic fluid supply and configured to deliver the therapeutic drug through the port.
14. The medical system of claim 13, further comprising a hub disposed between and in communication with the therapeutic fluid supply and the medical device.
15. The medical system of claim 14, further comprising an inflation fluid supply reservoir in fluid communication with the medical device.
16. The medical system of claim 15, wherein the hub comprises a first portion coupled to the inflation fluid supply reservoir and a second portion coupled to the therapeutic fluid supply source.
17. The medical system of claim 16, wherein when inflated, the expandable element extends partially around the outer surface of the injection tube.
18. The medical system of claim 16, wherein the syringe has a proximal portion and a distal portion opposite the proximal portion, the distal portion of the syringe being coupled to the expandable element.
19. The medical system of claim 18, wherein the expandable element includes a recessed area, the distal portion of the syringe being received within the recessed area.
20. A method for targeted pulmonary denervation, the method comprising: A therapeutic fluid supply having a therapeutic drug and a medical device in fluid communication with the therapeutic fluid supply are provided, the medical device comprising: expandable element; and an injection tube having a proximal portion and a distal portion, the distal portion coupled to and extending outwardly from the expandable element and defining a port configured to deliver the therapeutic drug to a target tissue region within a target bronchus; advancing the medical device through the trachea of a mammal and positioning the expandable element within the target bronchus; inflating the expandable element so that the distal portion of the injector tube pierces the wall of the target bronchus and contacts the target tissue area; and The therapeutic drug is delivered to the target tissue area to denervate the target bronchus.
